ArticleJournal of clinical medicine2023

Real-World Efficacy and Safety of an 8-Week Glecaprevir/Pibrentasvir Regimen in Children and Adolescents with Chronic Hepatitis C-Results of a Multicenter EpiTer-2 Study.

Malgorzata Pawlowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.